Stay updated on CT-P17 vs Humira in Active RA: Clinical Trial

Sign up to get notified when there's something new on the CT-P17 vs Humira in Active RA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT-P17 vs Humira in Active RA: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A related-topics link to MedlinePlus Genetics was added for rheumatoid arthritis.
    Difference
    0.2%
    Check dated 2026-11-15T02:16:13.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The study record for CT-P17 compared with Humira is displayed, including its design, eligibility criteria, outcomes, locations, and study documents.
    Difference
    46%
    Check dated 2026-11-08T05:12:37.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.2 to v3.8.0 while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:04:40.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition update and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T02:05:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T01:49:38.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:25:37.000Z thumbnail image

Stay in the know with updates to CT-P17 vs Humira in Active RA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT-P17 vs Humira in Active RA: Clinical Trial page.